Amcor (AMCR) Proxy filing summary

Executive summary

• Fiscal 2026 was the first full year post-acquisition of Berry, with integration delivering $285 million in synergies, 10% above expectations, and a clear path to a $650 million three-year synergy target.

• Adjusted EPS rose 13% to $4.02, with annual sales of $23.5 billion and net income of $1.1 billion; organic volume growth returned in Q4.

• Five non-core businesses were divested, sharpening focus on high-growth categories like nutrition, healthcare, beauty, and wellness.

• $1.2 billion was returned to shareholders via dividends, with a continued commitment to a strong balance sheet and reduced leverage.

• Sustainability and innovation remain central, with $170 million invested annually in R&D and a global portfolio of recyclable or recycle-ready products.

Voting matters and shareholder proposals

• Shareholders will vote on: re-election of ten directors, ratification of PwC as auditor, advisory say-on-pay, renewal of share repurchase authorization, and approval of the 2026 Omnibus Management Share Plan.

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board comprises ten nominees, all independent except the CEO; average tenure is 5.7 years and average age is 65.1.

• Board refreshment and diversity are emphasized, with 50% gender or ethnic diversity.

• Independent Chairman and Deputy Chairman roles are maintained; annual elections and comprehensive evaluations are conducted.

• Committees include Audit, Compensation, Nominating and Corporate Governance, and Executive, all with independent members.